Status:
COMPLETED
Obstructive Sleep Apnoea in Patients With Type 1 Diabetes
Lead Sponsor:
University of Birmingham
Collaborating Sponsors:
Heart of England NHS Trust
Conditions:
Type 1 Diabetes
Obstructive Sleep Apnoea
Eligibility:
All Genders
18+ years
Brief Summary
The primary aim of this study is to assess the relationship between obstructive sleep apnoea (OSA) and cardiac autonomic neuropathy (CAN) in patients with T1D. The secondary aims of this study are to...
Detailed Description
Obstructive sleep apnoea (OSA) has been reported to be very common in patient with type 2 diabetes (T2D), and this relation is expected as both conditions share obesity as a common risk factor. Despit...
Eligibility Criteria
Inclusion
- T1DM patient aged 18 and above, who was diagnosed more than 4 years ago.
- Able to give informed consent.
- Has sufficient proficiency in English to verbally answer interview questions.
Exclusion
- Past medical history of severe respiratory disorders including treated OSA.
- Patients using oxygen supplements.
- Patients with end-stage renal disease receiving dialysis.
- Pregnancy.
- Dementia.
- End stage diseases with life expectancy below 6 months.
- Patients with implantable devices
- Patients with known atrial fibrillation
Key Trial Info
Start Date :
February 14 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 27 2019
Estimated Enrollment :
47 Patients enrolled
Trial Details
Trial ID
NCT03481361
Start Date
February 14 2018
End Date
June 27 2019
Last Update
September 7 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Birmingham Heartlands Hospital, Heart of England NHS Foundation Trust
Birmingham, United Kingdom, B9 5SS